European Patent Office: Patentees remain in control

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

European Patent Office: Patentees remain in control

In appeal proceedings before the EPO, patentees and applicants frequently withdraw failed requests at the end of oral proceedings. For example, if the patentee's second auxiliary request is allowed, whereas the main and first auxiliary requests are rejected, most patentees will routinely withdraw the main and first auxiliary requests. Such withdrawal may in particular be made with a view to expediting the Board of Appeals' subsequent preparation of the written decision, as no written reasoning is to be prepared in respect of withdrawn requests.

In proceedings pertaining to EPO decision T 1477/15 dated February 23 2017 (made available online on July 26 2017), the Board was prompted to consider the allowability of such withdrawal of requests. The patentee's main requests as well as the first and second auxiliary requests had been rejected during the course of the oral proceedings, whereas the third auxiliary request had succeeded. The second auxiliary request corresponded to the request held allowable by the first-instance department in the decision under appeal. At the end of the oral proceedings in appeal, the patentee withdrew the first and second auxiliary requests. The opponents took the view that they had a right to a substantiated decision on their successful appeal against the impugned decision, so the patentee had no right to withdraw the request.

Referring to Article 113(2) EPC, according to which the EPO can only decide on the text submitted by the applicant or patentee, the Board, however, held that there was no basis in the European Patent Convention for not allowing the patentee to withdraw the contested requests. The Board further noted that "it is generally accepted that in appeal proceedings the principle of party disposition applies, meaning that parties can put forward, withhold or withdraw their requests as they see fit". The Board therefore had no power to object to the patentee's withdrawal of the first and second auxiliary requests.

Applicants and patentees are thus reassured that they remain in control of the requests that will eventually be scrutinised in the appeal boards' written decisions.

frederiksen.jpg

Jakob Pade Frederiksen



Inspicos P/S

Kogle Allé 2

DK-2970 Hoersholm

Copenhagen, Denmark

Tel: +45 7070 2422

Fax: +45 7070 2423

info@inspicos.com

www.inspicos.com

more from across site and SHARED ros bottom lb

More from across our site

The US decision marks a rare grant of a request under the Uniform Fraudulent Transfer Act in a patent case
Stobbs has applied to strike out a contempt of court application filed against the firm and two of its lawyers
With trademark volumes surging, trademark teams need to think beyond traditional clearance searches, towards a continuous, intelligence-led workflow, says Meghan Medeiros of Corsearch
Brazilian in-house counsel say law firms’ technology investments have not translated into tangible benefits, meaning tech use is a minor factor when selecting advisers
A lack of comfort among some salaried partners shows why law firms must actively foster inclusion, not merely focus on diversity mandates
Arrival of Laura Alonso, alongside a team of 11, will bring ‘significant value’ to ECIJA clients, says CEO
In the first of a two-part article, lawyers at Spruson & Ferguson and Marshall Gerstein provide an overview of China’s system for appealing against patent invalidation decisions
Lawyers and corporate leaders at INTA’s Business of M&A conference in New York discussed how cross-practice collaboration and early in-house involvement can help deals
Lily Li, partner at Morrison Foerster, shares how her litigation team helped secure victory at the ITC in a patent infringement case
Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires
Gift this article